Immune mediated Diseases-Vaccines

 

Patients with immune-mediated inflammatory diseases (IMID) such as RA, IBD or psoriasis, are at increased risk of infection, partially because of the disease itself, but mostly because of treatment with immunomodulatory or immunosuppressive drugs. In spite of their elevated risk for vaccine-preventable disease, vaccination coverage in IMID patients is surprisingly low. This review summarizes current literature data on vaccine safety and efficacy in IMID patients treated with immunosuppressive or immunomodulatory drugs and formulates best-practice recommendations on vaccination in this population. Especially in the current era of biological therapies, including TNF-blocking agents, special consideration should be given to vaccination strategies in IMID patients. Clinical evidence indicates that immunization of IMID patients does not increase clinical or laboratory parameters of disease activity. Live vaccines are contraindicated in immunocompromized individuals, but non-live vaccines can safely be given. Although the reduced quality of the immune response in patients under immunotherapy may have a negative impact on vaccination efficacy in this population, adequate humoral response to vaccination in IMID patients has been demonstrated for hepatitis B, influenza and pneumococcal vaccination. Vaccination status is best checked and updated before the start of immunomodulatory therapy: live vaccines are not contraindicated at that time and inactivated vaccines elicit an optimal immune response in immunocompetent individuals.

  • Auto Immune Diseases- Vaccines
  • Immunization In Immuno-compromised People
  • Latest Vaccine Development
  • Complications In HIV Patients
  • Others

 

    Related Conference of Immune mediated Diseases-Vaccines

    September 18-19, 2017

    20th Global Summit & Expo on Vaccines, Immunization & B2B

    (Global B2B Meetings in 1 Event) Houston, Texas USA
    October 05-07, 2017

    World Vaccines and Immunization Congress

    Osaka, Japan
    October 30-31, 2017

    19th International Vaccines & B2B Congress

    Chicago, USA

    Immune mediated Diseases-Vaccines Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in